Zai Lab (ZLAB) Cash & Current Investments (2016 - 2026)

Zai Lab (ZLAB) posted Cash & Current Investments of $751.3 million for Q1 2026, down 3.62% sequentially from $779.6 million in Q4 2025, and down 12.36% YoY from $857.3 million in Q1 2025.

Zai Lab (ZLAB) Cash & Current Investments (2016 - 2026) Analysis & Trends

Zai Lab has reported Cash & Current Investments for 11 years, with the latest figure at $751.3 million in Q1 2026.

  • Quarterly Cash & Current Investments fell 12.36% year-over-year to $751.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $751.3 million (down 12.36% YoY) and the FY2025 annual result came in at $779.6 million, changed 0.01% from the prior year.
  • Cash & Current Investments slipped to $751.3 million in Q1 2026 per ZLAB's latest filing, from $779.6 million in the prior quarter.
  • Over five years, Cash & Current Investments peaked at $1.3 billion in Q1 2022 and troughed at $716.1 million in Q3 2024.
  • A 5-year average of $890.7 million and a median of $820.4 million in 2023 frame the typical range for Cash & Current Investments.
  • The sharpest annual moves came in 2022 and 2023: Cash & Current Investments rose 29.49% in 2022, then slumped 30.37% in 2023.
  • Over 5 years, Cash & Current Investments stood at $1.0 billion in 2022, then dropped by 20.03% to $806.5 million in 2023, then declined by 3.32% to $779.7 million in 2024, then retreated by 0.01% to $779.6 million in 2025, then declined by 3.62% to $751.3 million in 2026.
  • According to Business Quant data, Cash & Current Investments over the past three periods registered $751.3 million, $779.6 million, and $817.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 7.85 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 7.99 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 5.18 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 5.10 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 8.46 Mn
7 Royalty Pharma 33.72 Bn 35.84 Bn - 836.99 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 3.31 Bn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 1.16 Bn
10 Zai Lab 2.91 Bn 2.20 Bn 58.15 Mn 707.52 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 707.52 Mn
Mar 31, 2026 751.32 Mn
Dec 31, 2025 779.57 Mn
Sep 30, 2025 817.16 Mn
Jun 30, 2025 832.27 Mn
Mar 31, 2025 857.26 Mn
Dec 31, 2024 779.67 Mn
Sep 30, 2024 716.09 Mn
Jun 30, 2024 730.05 Mn
Mar 31, 2024 750.78 Mn
Dec 31, 2023 806.45 Mn
Sep 30, 2023 820.41 Mn
Jun 30, 2023 874.66 Mn
Mar 31, 2023 930.39 Mn
Dec 31, 2022 1.01 Bn
Sep 30, 2022 1.12 Bn
Jun 30, 2022 1.26 Bn
Mar 31, 2022 1.31 Bn
Dec 31, 2021 1.41 Bn
Sep 30, 2021 1.57 Bn